 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Analysts, Investors 'Troubled' as Affymetrix's Preliminary Q3 Revenues Miss Estimates
October 09, 2012
Analysts, Investors 'Troubled' as Affymetrix's Preliminary Q3 Revenues Miss Estimates
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BlueGnome, Expanding Cyto Menu, Debuts High-Resolution, 850K SNP Chip on Illumina Platform
June 18, 2013 / BioArray News - GeneSeek Sees 'Double-Digit' Growth in Demand for Agrigenomics SNP Array Services
January 29, 2013 / BioArray News - Autism-Associated Variants Uncovered by Population Diagnostics, SickKids Team Could Yield Dx Tests
December 11, 2012 / BioArray News - Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012 / BioArray News - Roche Executive Says Firm is Seeking Buyer for NimbleGen Array Business
June 12, 2012 / BioArray News